SCHEMBL21362823

SCHEMBL21362823

COc1ccc(C(c2ccc(C)cc2Br)C2CO2)cc1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.35
SLC6A2 P23975 2/20 0.34
SLC6A4 P31645 2/20 0.34
SLC6A3 Q01959 1/20 0.34
P2RX3 P56373 1/20 0.34
MAPT P10636 5/20 0.34
L3MBTL1 Q9Y468 4/20 0.34
HPGD P15428 3/20 0.34
NPC1 O15118 3/20 0.34
RAB9A P51151 3/20 0.34
TDP1 Q9NUW8 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
KMT2A Q03164 3/20 0.33
KDM1A O60341 2/20 0.33
ABL1 P00519 1/20 0.33
RIN1 Q13671 1/20 0.33
LMNA P02545 3/20 0.33
MAPK1 P28482 1/20 0.33
ACHE P22303 1/20 0.33
MEN1 O00255 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20157992 0.78 TOP2A (0.40) MAPTL3MBTL1HPGDNPC1RAB9A
SCHEMBL20157895 0.68 TOP2A (0.37) MAPTL3MBTL1HPGDNPC1RAB9A
SCHEMBL20158171 0.67 LMNA (0.41) SLC6A2MAPTL3MBTL1HPGDNPC1
SCHEMBL11883 0.67 ACHE (0.62) MAPTL3MBTL1HPGDNPC1RAB9A
SCHEMBL9774382 0.66 LMNA (0.44) NPC1RAB9ASMN1; SMN2KMT2AKDM1A
SCHEMBL84653 0.65 LMNA (0.47) HPGDNPC1RAB9ASMN1; SMN2KMT2A
SCHEMBL16798294 0.65 LMNA (0.47) NPC1RAB9ASMN1; SMN2KMT2AKDM1A
SCHEMBL21362664 0.65 ABL1 (0.37) MAPTL3MBTL1HPGDNPC1RAB9A
SCHEMBL20158035 0.64 ABL1 (0.36) MAPTL3MBTL1HPGDNPC1RAB9A
SCHEMBL29447058 0.63 ACHE (0.62) MAPTL3MBTL1HPGDNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3539960-A1 NITROGENOUS MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF Luoxin Pharmaceutical (Shanghai) Co., Ltd. (CN) 2019-09-18 EP disclosed